GPT-enabled conversational AI provider Hyro announced it finalized an extension of its Series B funding round. The company told MobiHealthNews that the total Series B funding equates to $35 million, bringing the company's total raise to $50 million.
Healthier Capital led the extension, joining the company's previous investors, Liberty Mutual, Macquarie Capital and Black Opal Ventures.
Amir Dan Rubin founded Healthier Capital. He previously served as CEO of Amazon's One Medical, executive vice president at Optum/UnitedHealth Group and CEO at Stanford Health Care.
WHAT IT DOES
New York-based Hyro offers a conversational AI-enabled call center for providers that allows for automated conversations with their patients. It also provides real-time analytics, insights from patient interactions and a GPT-powered assistant, dubbed Spot, that offers explainability around AI outputs.
The company plans to expand its healthcare footprint and introduce tools for the payer and pharmaceutical markets. In a statement, it said it will expand its outbound calling offering next year, focus on appointment no-shows and "encourage patients to switch from reactive to proactive care." It will also enhance its analytics suite.
"Healthier Capital's investment is yet another signal to the market of the steadfast trust we've established in our ability to deliver stellar outcomes at Hyro, catching the attention of Healthier Capital's founder, Amir Dan Rubin, after his tenure in healthcare innovation. We are thrilled to have the Healthier Capital team in our corner," Israel Krush, CEO and cofounder of Hyro, said in a statement.
MARKET SNAPSHOT
Last year, Hyro raised $20 million in Series B funding led by Macquarie Capital, which it said it would use to expand its workforce, grow strategic partners and further build its platform.
The company also announced a partnership with patient communication platform Artera, formerly Well Health, to launch Artera Care Assist, an AI-powered virtual assistant powered by Hyro that can be embedded into a health provider's website to answer common patient questions.
In 2019, Hyro, formerly Airbud, raised $4 million in seed funding and, in 2021, secured $10.5 million in Series A funding.
